These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 6184569)

  • 61. [Initial experience. Comparative study of verapamil and nifedipine in the treatment of coronary insufficiency. Evaluation by a cycloergometric test].
    Figueira RH; Guimarães F; Wagner M; Bozza AE; Dohmann HJ
    Arq Bras Cardiol; 1978 Feb; 31 Suppl 1():39-43. PubMed ID: 354612
    [No Abstract]   [Full Text] [Related]  

  • 62. Factors influencing the hypotensive effects of calcium antagonists.
    Erne P; Bolli P; Bertel O; Hulthen UL; Kiowski W; Muller FB; Buhler F
    Hypertension; 1983; 5(4 Pt 2):II97-102. PubMed ID: 6345378
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Instant and sustained-release verapamil in the treatment of essential hypertension.
    Midtbø K; Hals O; van der Meer J; Storstein L; Lauve O
    Am J Cardiol; 1986 Feb; 57(7):59D-63D. PubMed ID: 3513516
    [TBL] [Abstract][Full Text] [Related]  

  • 64. The use of nifedipine as third line therapy in the treatment of severe hypertension.
    Kendall MJ; Dean S
    Postgrad Med J; 1983; 59 Suppl 2():119-22. PubMed ID: 6136958
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Dose initiation of calcium antagonists in the treatment of hypertension.
    Müller FB; Erne P; Hotz M; Bolli P; Follath F; Bühler FR
    J Clin Hypertens; 1986 Sep; 2(3 Suppl):118S-124S. PubMed ID: 3794763
    [No Abstract]   [Full Text] [Related]  

  • 66. Studies on verapamil in the treatment of essential hypertension: a review.
    Midtbø K; Hals O; Lauve O; van der Meer J; Storstein L
    Br J Clin Pharmacol; 1986; 21 Suppl 2(Suppl 2):165S-171S. PubMed ID: 3530299
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Verapamil and nifedipine in combination for the treatment of hypertension.
    Kaesemeyer WH; Carr AA; Bottini PB; Prisant LM
    J Clin Pharmacol; 1994 Jan; 34(1):48-51. PubMed ID: 8132851
    [TBL] [Abstract][Full Text] [Related]  

  • 68. [Calcium antagonists and myocardial "responsitivity"].
    Manzoli U; Domenichelli B; Coppola E; Lucente M; Schiavoni G; Mazzari M; Scabbia E
    Boll Soc Ital Cardiol; 1978; (1 Suppl):45-59. PubMed ID: 757679
    [No Abstract]   [Full Text] [Related]  

  • 69. [The comparative efficacy and prognosis of the long-term treatment with korinfar of men and women suffering from hypertension].
    Maslova NP; Baranova EI; Barabanova NG
    Ter Arkh; 1991; 63(8):52-5. PubMed ID: 1792619
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Effect of combination of edible oils on blood pressure, lipid profile, lipid peroxidative markers, antioxidant status, and electrolytes in patients with hypertension on nifedipine treatment.
    Sudhakar B; Kalaiarasi P; Al-Numair KS; Chandramohan G; Rao RK; Pugalendi KV
    Saudi Med J; 2011 Apr; 32(4):379-85. PubMed ID: 21483997
    [TBL] [Abstract][Full Text] [Related]  

  • 71. [Calcium antagonists in the management of hypertension].
    Kaburagi T; Yokoyama S
    Nihon Rinsho; 1984 Feb; 42(2):409-15. PubMed ID: 6716696
    [No Abstract]   [Full Text] [Related]  

  • 72. A comparison of the effects of nifedipine and verapamil on exercise performance in patients with mild to moderate hypertension.
    Halperin AK; Icenogle MV; Kapsner CO; Chick TW; Roehnert J; Murata GH
    Am J Hypertens; 1993 Dec; 6(12):1025-32. PubMed ID: 8136093
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Combination therapy with beta-adrenoceptor blockers and calcium antagonists.
    Dargie HJ
    Br J Clin Pharmacol; 1986; 21 Suppl 2(Suppl 2):155S-160S. PubMed ID: 2875727
    [TBL] [Abstract][Full Text] [Related]  

  • 74. The effect of enalapril and calcium antagonists on blood pressure and cerebral perfusion in elderly hypertensives.
    Traub YM; Ayache AS; Groshar D
    J Hypertens Suppl; 1991 Dec; 9(6):S378-9. PubMed ID: 1819000
    [No Abstract]   [Full Text] [Related]  

  • 75. The treatment of hypertension with verapamil.
    Lewis GR; Morley KD; Lewis BM; Bones PJ
    N Z Med J; 1978 May; 87(612):351-4. PubMed ID: 353597
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Nifedipine in the treatment of hypertension: report of a double-blind controlled trial.
    Bayley S; Dobbs RJ; Robinson BF
    Br J Clin Pharmacol; 1982 Oct; 14(4):509-12. PubMed ID: 6753886
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Sustained-release verapamil as a first-step drug in the treatment of mild to moderate hypertension.
    Karcier SM; Orbay B; Ozder AB; Gürses N; Aytekin S; Satar S; Oztürk M; Demiroğlu C
    J Int Med Res; 1989; 17(3):268-76. PubMed ID: 2767329
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Quality of life in the treatment of hypertension. The effect of calcium antagonists.
    Fletcher A; Bulpitt C
    Drugs; 1992; 44 Suppl 1():135-40. PubMed ID: 1283577
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Calcium blockers: more than angina.
    Merz B
    JAMA; 1982 Sep; 248(11):1285-7. PubMed ID: 7050429
    [No Abstract]   [Full Text] [Related]  

  • 80. Clinical trials of verapamil: comparative studies of verapamil with beta-blockers and nifedipine.
    Jackson SH
    Br J Clin Pract Suppl; 1988 Apr; 60():45-7. PubMed ID: 2908234
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.